CORONA Remedies Limited (NSE:CORONA)

CORONA Remedies Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	18.3	32.2	31.56	144.94	68.24
Short-Term Investments	270	648.2	13.98	59.69	69.92
Cash & Short-Term Investments	288.3	680.4	45.54	204.63	138.16
Cash Growth	-57.63%	1394.07%	-77.75%	48.11%	-80.94%
Accounts Receivable	1,456	1,183	999.34	869.91	743.52
Other Receivables	6.7	31.9	4.02	2.67	5.98
Receivables	1,465	1,219	1,007	876.96	753.73
Inventory	1,250	1,295	983.45	1,054	739.47
Prepaid Expenses	19.1	37	33.85	27.59	17.3
Other Current Assets	460.9	157.9	829.22	751.7	1,187
Total Current Assets	3,483	3,389	2,899	2,915	2,836
Property, Plant & Equipment	4,343	3,847	3,116	2,488	1,665
Long-Term Investments	1,529	259.6	275	399.86	437.77
Other Intangible Assets	2,628	1,712	1,927	5.34	95.3
Long-Term Deferred Tax Assets	-	-	-	42.52	37.83
Other Long-Term Assets	68	91.7	87.76	99.94	42.08
Total Assets	12,051	9,299	8,306	5,950	5,114

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	1,471	1,435	1,143	943.7	846
Accrued Expenses	86.8	94.7	67.41	88.41	69.62
Short-Term Debt	1,269	107	311.42	23.31	20.67
Current Portion of Long-Term Debt	160	360	360	-	151.33
Current Portion of Leases	31.1	25.2	21.65	17.92	58.43
Current Income Taxes Payable	83.8	63.2	48.05	38.32	33.8
Other Current Liabilities	510.7	310.6	290.44	262.05	298.61
Total Current Liabilities	3,612	2,396	2,242	1,374	1,478
Long-Term Debt	-	160	670	-	165.38
Long-Term Leases	188.8	210.2	226.48	238.37	68.24
Long-Term Unearned Revenue	-	-	0.14	4.91	4.91
Pension & Post-Retirement Benefits	300.3	135.9	109.55	76.53	56.56
Long-Term Deferred Tax Liabilities	121.6	83	42.86	-	-
Other Long-Term Liabilities	360.4	250.2	210.74	171.52	131.02
Total Liabilities	4,583	3,235	3,502	1,865	1,905

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	611.6	611.6	611.6	611.6	510.51
Additional Paid-In Capital	415.8	415.8	415.84	415.84	411.97
Retained Earnings	6,441	5,036	3,777	3,058	2,283
Total Common Equity	7,469	6,063	4,804	4,085	3,205
Shareholders' Equity	7,469	6,063	4,804	4,085	3,209
Total Liabilities & Equity	12,051	9,299	8,306	5,950	5,114

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	1,649	862.4	1,590	279.6	464.05
Net Cash (Debt)	-1,360	-182	-1,544	-74.97	-325.89
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	-22.24	-2.98	-25.25	-1.29	-6.38
Filing Date Shares Outstanding	61.16	61.16	61.16	61.16	51.05
Total Common Shares Outstanding	61.16	61.16	61.16	61.16	51.05
Working Capital	-128.6	992.8	657.24	1,541	1,358
Book Value Per Share	122.12	99.14	78.55	66.80	62.78
Tangible Book Value	4,840	4,352	2,877	4,080	3,110
Tangible Book Value Per Share	79.14	71.16	47.04	66.71	60.92
Land	81.8	81.8	81.79	81.79	81.79
Buildings	808.1	479.4	475	472.35	464.4
Machinery	2,342	1,606	1,427	1,248	984.82
Construction In Progress	1,431	1,860	1,206	647.09	142.29

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 23, 2026

Data Sources Report a data error